Dr. John Moran accepts position as Chair of Intelomed’s Scientific Advisory Board

WEXFORD, Pa., Feb. 27, 2014 /PRNewswire/ -- Dr. John Moran has accepted the position as Chair of the Scientific Advisory Board for Intelomed, Inc.  "We are thrilled that John has accepted this position.  He is a thought leader with terrific experience and a passion to improve patient care," said Frank Amoruso, President and CEO.  "Dr. Moran's leadership of our advisory board will insure the utilization of our experts in continuing our great progress toward the improvement of patient care in our target markets.  His advice and guidance are very highly regarded, and we feel privileged to have him lead our Scientific Advisory Board."  When asked about his decision to accept the position, Dr. Moran said "I am very impressed with the innovation at Intelomed.  There is great deal of innovative thinking on the team, and I believe CVInsight to be a much needed tool to address many of the issues facing the hemodialysis and long term nursing care markets." 

About Intelomed

Intelomed is a privately held medical technology company, established in 2005 and headquartered in Pittsburgh, Pennsylvania. They are focused on developing innovative software and non-invasive devices for monitoring cardiovascular stability in real-time. Intelomed's ability to provide intelligent operational medicine via their technology will directly and positively impact the initial areas of dialysis, cardiology, and trauma.  

Safe Harbor Statement

Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on third party manufacturers to produce our goods on time and to our specifications, and implementation of our sales strategy.

SOURCE Intelomed, Inc.